Literature DB >> 1198070

A solid-phase radioimmunoassay for C1q-binding immune complexes. I. Delta IgG as indicator molecule.

S E Svehag.   

Abstract

A solid-phase radioimmunoassay for detection of circulating C1q-binding immune complexes (IC) or heat-aggregated IgG (delta IgG) is described. Purified human C1q protein was adsorbed to a fixed area of polystyrene tube surface for 1 hr at 22 degrees C, pH 7.3, mu 0.15. Binding of delta IgG or IC to solid-phase C1q at 22 degrees C progressed over several hours and was enhanced at low mu (0.05). Heating of C1q (56 degrees C for 30 min) reduced the binding by 85%-90%. Binding of IC or delta IgG was retained after several weeks' storage of solid-phase C1q at 4 degrees C. Detection of 2-5 ng delta IgG and less than 50 ng IC (in antibody excess) was achieved in competitive binding or inhibition tests with [125I]delta IgG. Preliminary testing of 48 human sera indicated the usefulness of the assay for detection of IC in patient sera.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1198070     DOI: 10.1111/j.1365-3083.1975.tb02677.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  15 in total

1.  Circulating immune complexes in ulcerative colitis. I. Correlation to disease activity.

Authors:  H Nielsen; V Binder; H Daugharty; S E Svehag
Journal:  Clin Exp Immunol       Date:  1978-01       Impact factor: 4.330

2.  Studies on circulating soluble immune complexes of the liver disease. 1. Inhibition assay of polyclonal rheumatoid factor binding to IgG-sepharose.

Authors:  J Narumoto; T Arima; K Kunishi; T Yasuhara; K Suwaki; H Shimomura; H Nagashima
Journal:  Gastroenterol Jpn       Date:  1979-12

Review 3.  Immune complexes in human diseases: a review.

Authors:  A N Theofilopoulos; F J Dixon
Journal:  Am J Pathol       Date:  1980-08       Impact factor: 4.307

4.  Circulating immune complex in the mucocutaneous lymph node syndrome.

Authors:  A Furuse; I Matsuda
Journal:  Eur J Pediatr       Date:  1983-10       Impact factor: 3.183

Review 5.  Pitfalls in the methodology for detection of immune complexes.

Authors:  R Heimer; S Per
Journal:  Surv Immunol Res       Date:  1982

6.  Prevalence and persistence of C1q binding activity in healthy subjects.

Authors:  S M Walker; S F Al Khateeb
Journal:  J Clin Pathol       Date:  1981-04       Impact factor: 3.411

7.  Autoimmune implications of immune complexes in clinical variants of hepatitis B.

Authors:  H Daugharty; K Kelley; C Moore; T Hersh
Journal:  Clin Exp Immunol       Date:  1979-08       Impact factor: 4.330

8.  Detection of immune complexes. The use of radioimmunoassays with Clq and monoclonal rheumatoid factor.

Authors:  A Gabriel; V Agnello
Journal:  J Clin Invest       Date:  1977-05       Impact factor: 14.808

9.  Studies on circulating soluble immune complexes of the liver disease. 6. Comparative studies of 125I-pRF inhibition assay, 125I-Clq inhibition assay and 125I-Clq binding assay.

Authors:  J Narumoto
Journal:  Gastroenterol Jpn       Date:  1981

10.  Studies on circulating immune complexes of the liver disease. 4. Clq binding activity.

Authors:  T Arima; J Narumoto; H Shimomura; K Suwaki; K Kunishi; T Yasuhara; H Nagashima
Journal:  Gastroenterol Jpn       Date:  1980
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.